Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: Predictions across species

Environmental Health Perspectives

Volumn 105, Issue 10, 1997, Pages 1116-1124

  Tong, Weida ^a   Perkins, Roger ^a   Strelitz, Richard ^a   Collantes, Elizabeth R ^b   Keenan, Susan ^b   Welsh, William J ^b   Branham, William S ^c   Sheehan, Daniel M ^c  

^a Logicon ROW Sciences   (United States)

^b UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

CODESSA; CoMFA; Endocrine disrupters; Estrogen receptor; Estrogens; QSAR; Quantitative structure activity relationships; Relative binding affinity; Species to species extrapolation; Xenoestrogens

Indexed keywords

ENVIRONMENTAL CHEMICAL; ESTROGEN; ESTROGEN RECEPTOR;

ARTICLE; BINDING AFFINITY; CATTLE; COMPUTER PROGRAM; CYTOSOL; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BINDING; SCREENING; SPECIES DIFFERENCE; UTERUS; WILDLIFE;

BOS TAURUS;

EID: 0031410762     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.971051116     Document Type: Article

References (49)

1. McLachlan JA, ed. Estrogens in the Environment, II: Influences on Development. New York:Elsevier, 1985.
2. Mishell JR. Noncontraceptive benefits of oral contraceptives. J Reprod Med 38(suppl 12):1021-1029 (1993).
3. Barrett-Connor E. Risk and benefits of replacement estrogen. Annu Rev Med 43:239-251 (1992).
4. Herbst AL, Bern HA. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. New York: Thieme-Stratton Inc., 1981.
5. Colburn T, Clement C. Chemically-induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton, NJ: Princeton Scientific Publishing, 1992.
6. Colburn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101(5):378-384 (1993).
7. Hileman B. Environmental estrogens linked to reproductive abnormalities, cancer. Chem Eng News 72:19-23 (1994).
8. Kavlock RJ, Daston GP, DeRosa C, Fenner- Crisp P, Gray LE, Kaattari, Lucier G, Luster M, Mac MJ, Maczka C. Research needs for the risk assessment of health and environmental effects of endocrine disrupters: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect 104(suppl 4):715-740 (1996).
9. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).
10. Compilation of Laws Enforced by the U.S. Food and Drug Administration and Related Statutes. Vol 2. Washington, DC:U.S. Government Printing Office, 1996.
11. Safe Drinking Water Act Amendments of 1996. Public Law 104-182. 104th Congress, 1996.
12. Katzenellenbogen JA. The structural pervasiveness of estrogenic activity. Environ Health Perspect 103(suppl 7):99-101 (1995).
13. Korach KS, McLachlan JA. Techniques for detection of estrogenicity. Environ Health Perspect 103(suppl 7):5-8 (1995).
14. Branham WS, Zehr DR, Sheehan DM. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc Soc Exp Biol Med 203:297-303 (1993).
15. Medlock KL, Branham WS, Sheehan DM. Effects of coumestrol and equol on the developing reproductive tract of the rat. Proc Soc Exp Biol Med 208:67-71 (1995).
16. Miksicek RJ. Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exp Biol Med 208:44-50 (1995).
17. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The ESCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103(suppl 7):113-122 (1995).
18. Liskowski L, Rose DP. Experience with a simple method for estrogen receptor assay in breast cancer. Clin Chim Acta 67:175-182 (1976).
19. Anstead GM, Carlson KE, Katzenellenbogen JA. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62:268-303 (1997).
20. Fujita T, Iwasa J, Mansch C. A new substituent constant, π, derived from partition coefficient. J Am Chem Soc 86:5175-5180 (1964).
21. Hansch C, Leo A. Exploring QSAR- Fundamentals and Applications in Chemistry and Biology. Washington, DC:The American Chemical Society, 1995.
22. Bradbury SP. Quantitative structure-activity relationship and ecological risk assessment: an overview of predictive aquatic toxicology research. Toxicol Lett 79:229-237 (1995).
23. Hansch C, Telzer BR, Zhang L. Comparative QSAR in toxicology: examples from teratology and cancer chemotherapy of aniline mustards. Critical Rev Toxicol 25(1):67-89 (1995).
24. Cramer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959-5967 (1988).
25. Tong W, Collantes E, Chen Y, Welsh WJ. A comparative molecular field analysis study of N- benzylpiperidines as acetylcholinesterase inhibitors. J Med Chem 39(2):380-387.
26. Collantes E, Tong W, Welsh WJ. Use of moment of inertia in comparative molecular field analysis to model chromatographic retention of nonpolar solutes. Anal Chem 68:2038-2043 (1996).
27. Waller CL, Minor DL, McKinney JD. Using three-dimensional quantitative structure-activity relationships to examine estrogen receptor binding affinities of polychlorinated hydroxy- biphenyls. Environ Health Perspect 103: 702-707 (1995).
28. Waller CL, Oprea TI, Chae K, Park HK, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE. Ligand-based identification of environmental estrogens. Chem Res Toxicol 9:1240-1248 (1996).
29. Bradbury SP, Mekenyan OG, Ankley GT. Quantitative structure-activity relationships for polychlorinated hydroxybiphenyl estrogen receptor binding affinity - an assessment of conformer flexibility. Environ Toxicol Chem 15:1945-1954 (1996).
30. Gantchev TG, Ali H, van Lier JE. Quantitative structure-activity relationships/comparative molecular field analysis (QSARs/CoMFA) for receptor-binding properties of halogenated estradiol derivatives. J Med Chem 37:4164-4176 (1994).
31. Tong W, Perkins R, Xing L, Welsh WJ, Sheehan DM. QSAR models for binding of estrogenic compounds to estrogen receptor α and α subtypes. Endocrinology 138:4022-4025 (1997).
32. Loughney DA, Schwender CF. A comparison of progestin and androgen receptor binding using the CoMFA technique. J Comput-Aided Mol Des 6:569-581 (1992).
33. Oprea TI, Garcia AE. Three-dimensional quantitative structure-activity relationship of steroid aromatase inhibitors. J Comput-Aided Mol Des 10:186-200 (1996).
34. Waller CL, Juma BW, Gray LE, Kelce WR. Three-dimensional quantitative structure-activity relationships for androgen receptor ligands. Toxicol Appl Pharmacol 137:219-227 (1996).
35. Welsh WJ, long W, Collantes ER, Chickos JS, Gagarin SG. Enthalpies of sublimition and formation of polycyclic aromatic hydrocarbons (PAHs) derived from comparative molecular field analysis (CoMFA): application of moment of inertia for molecular alignment. Thermochem Acta 290:55-64 (1996).
36. Katritzky AR, Mu L, Lobanov VS, Karelson M. Correlation of boiling points with molecular structure. 1. A training set of 298 diverse organics and a test set of 9 simple inorganics. J Phys Chem 100:10400-10407 (1996).
37. Katritzky AR, Ignatchenko ES, Barcode RA, Lobanov VS. Prediction of gas Chromatographic retention times and response factors using a general quantitative structure-property relationship treatment. Anal Chem 66:1799-1807 (1994).
38. Katritzky AR, Rachwal P, Law KW, Karelson M, Lobanov VS. Prediction of polymer glass transition temperatures using a general quantitative structure-property relationship treatment. J Chem Inf Comput Sci 36:879-884 (1996).
39. von Angerer E, Prekajac J, Strohmeier J. 2- Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. J Med Chem 27:1439-1447 (1984).
40. Polossek T, Ambros R, von Angerer S, Brandl G, Mannschreck A, von Angerer E. 6-Alkyl-12- formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity. J Med Chem 35:3537-3547 (1992).
41. von Angerer E, Biberger C, Holler E, Koop R, Leichtl S. 1-Carbamoylalkyl-2-phenylindoles: relationship between side chain structure and estrogen antagonism. J Steroid Biochem Mol Biol 49:51-62 (1994).
42. VanderKuur JA, Wiese T, Brooks SC. Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex. Biochem 32:7002-7008 (1993).
43. Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron 36: 3219-3228 (1980).
44. Wold S, Albano C, Dunn WJ III, Edlund U, Esbensen K, Geladi P, Hellberg S, Johansson E, Lindberg W, Sjostrom M, Multivariate data analysis in chemistry. In: Chemometrics: Mathematics and Statistics in Chemistry (Kowlaski B, ed). Dordrecht, The Netherlands: Reidel, 1984.
45. Gramer RD III, Bunce JD, Patterson DE. Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant Struct-Act Relat 7:18-25 (1988).
46. Beato M. Gene regulation by steroid hormones. Cell 56:335-344 (1989).
47. Green S, Walter P, Kumar V, Krust A, Bornett JM, Argos P, Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139 (1986).
48. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150-1154 (1986).
49. Sheehan DM, Branham WS. Dissociation of estrogen-induced uterine growth and ornithine decarboxylase activity in the postnatal rat. Teratog Carcinog Mutagen 7:411-422 (1987).